Key Pharmaceutical Regulation Issues for the New Administration episode artwork

EPISODE · Jan 6, 2025 · 43 MIN

Key Pharmaceutical Regulation Issues for the New Administration

from FDA Watch

In our first episode, Shelly and Wayne chat with Nikki Reeves, Partner in the FDA & Life Sciences practice at King & Spalding, and Brian Malkin, Associate General Counsel for Regulatory Law at Teva Pharmaceuticals. You'll hear their thoughts on the top priorities in pharmaceutical regulation for the next FDA commissioner and their insights on AI policy, patient voices, and other front-burner issues. In our headlines segment, Shelly and Wayne delve into these major developments: Pharma: More than 200,000 Prescriptions for Wegovy Filled Devices: FDA Announces Communication Pilot on Recalls Food: Fruits & Vegetables: Are They Really Safe? Cosmetics: FDA Issue Final Rule on Color Additive Certification Fees In our Resource Links segment, we listed key documents in our fore core areas. To view these links, subscribe, or find out more information about our podcast, visit FDAWatch.net. Want to be a sponsor, marketing partner, or guest, or provide feedback on the podcast? Email us at [email protected]. Music by Dvir Silver from Pixabay.

Episode metadata supplied by the publisher feed · Published Jan 6, 2025

Embed this episode

NOW PLAYING

Key Pharmaceutical Regulation Issues for the New Administration

0:00 43:08

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of FDA Watch?

This episode is 43 minutes long.

When was this FDA Watch episode published?

This episode was published on January 6, 2025.

Can I download this FDA Watch episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!